<p>The inhibition of enzymes is a highly practical area in drug development. In this study, twelve sulfonamide-containing chalcone derivatives (<b>9</b>–<b>20</b>) were synthesised. The inhibitory effects of these compounds on the isoenzymes carbonic anhydrase I (hCA I) and II (hCA II), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) were also investigated. These compounds demonstrated good in vitro inhibition of both hCA I and hCA II. They exhibited highly potent inhibitory effects on AChE and BChE (IC<sub>50</sub> values ranging from 7.75 to 49.60&#xa0;nM for AChE and 8.80 to 36.65&#xa0;nM for BChE), and the results were compared with the standard inhibitor Tacrine (IC<sub>50</sub>: 34.65&#xa0;nM for AChE and 26.65&#xa0;nM for BChE). Of the compounds tested, compound <b>15</b> showed excellent in vitro inhibition of AChE (IC<sub>50</sub>: 7.75&#xa0;nM) in the nanomolar range, while compound <b>20</b> showed the highest inhibition of BChE (IC<sub>50</sub>: 8.80&#xa0;nM). To validate the experimental results, molecular docking simulations were performed for all synthesised compounds, which proved to be consistent. Examination of the results indicates that the sulfonamide chalcone derivatives have potential activity against the target enzymes AChE and BChE at the molecular level.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Synthesis, characterization, enzyme inhibition evaluations, and docking calculations of sulfonamide chalcone derivatives

  • Gonca Çelik,
  • Tayfun Arslan,
  • Halil Gökce,
  • Eda Mehtap Özden,
  • İlhami Gülçin,
  • Nurettin Yaylı

摘要

The inhibition of enzymes is a highly practical area in drug development. In this study, twelve sulfonamide-containing chalcone derivatives (920) were synthesised. The inhibitory effects of these compounds on the isoenzymes carbonic anhydrase I (hCA I) and II (hCA II), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) were also investigated. These compounds demonstrated good in vitro inhibition of both hCA I and hCA II. They exhibited highly potent inhibitory effects on AChE and BChE (IC50 values ranging from 7.75 to 49.60 nM for AChE and 8.80 to 36.65 nM for BChE), and the results were compared with the standard inhibitor Tacrine (IC50: 34.65 nM for AChE and 26.65 nM for BChE). Of the compounds tested, compound 15 showed excellent in vitro inhibition of AChE (IC50: 7.75 nM) in the nanomolar range, while compound 20 showed the highest inhibition of BChE (IC50: 8.80 nM). To validate the experimental results, molecular docking simulations were performed for all synthesised compounds, which proved to be consistent. Examination of the results indicates that the sulfonamide chalcone derivatives have potential activity against the target enzymes AChE and BChE at the molecular level.